Swiss firm BioVersys signs deal with Shionogi for antibiotics research
Select your language
Generated with artificial intelligence.
Listening:
Swiss firm BioVersys signs deal with Shionogi for antibiotics research
Swiss biotech firm BioVersys has signed a research and licensing agreement with the Japanese pharmaceutical company Shionogi.
+Get the most important news from Switzerland in your inbox
Under the terms of the collaboration, BioVersys is entitled to upfront and short-term research payments of CHF5 million, as the Basel-based company announced on Wednesday.
Should Shionogi exercise a license option, approval and sales-based payments of up to CHF479 million ($604 million) tiered royalties on future sales would be added.
+ BioVersys is first Swiss IPO of 2025
The two companies want to drive forward a BioVersys program for the treatment of non-tuberculous mycobacteria. These pathogens can cause lung and skin infections and pathological swelling of the lymph nodes, particularly in people with weakened immune systems.
Translated from German by DeepL/jdp
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch
More
Relatives fear for 81-year-old Swiss detained in Tunisia
More
The global private education industry is coming for Switzerland’s expensive schools
More
Switzerland’s mood barometer reveals high satisfaction but cracks in unity
More
Swiss Abroad aim for seats in parliament
More
Silent power guzzlers: Switzerland’s booming data centres
News
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.